Life Sciences, Pharma & Healthcare

The largest life sciences practice at a top-tier full-service firm in the Netherlands

.. with a practice that spans the entire spectrum of legal services relevant to the pharmaceutical and healthcare industry and to biotech companies.

We have strength and depth across this multifaceted sector, and advise on all relevant angles of legal life sciences work: ranging from M&A, financing transactions, IPOs (on Euronext Amsterdam, NASDAQ or other venues), corporate and governance, licensing transactions (often on a global scale), competition, regulatory and IP strategic advice through to litigation, compliance and investigations.

Our in-house capabilities give us a unique position from which to advise clients involved in life sciences matters which are by nature, often multidisciplinary. We are regularly retained for major transactions in the life sciences sector and our litigation department handles several of the largest healthcare and life sciences cases in the Netherlands, ranging from patent litigation to class actions pertaining to faulty medical devices and medicine.

Contact

Lennard Keijzer

Partner

Reinier Kleipool

Partner

Gaby Smeenk

Partner

Anne Marie Verschuur

Partner

Related expertise

Intellectual Property Venture Capital Capital Markets Mergers & Acquisitions Litigation

Recent Matters

21 February 2025

Axcel acquires De Tandartsengroep from HC Partners through its portfolio company Oral Care to create Northern European dental group

De Brauw advises Axcel on the acquisition by its portfolio company Oral Care of Dutch dental care provider De Tandartsengroep from HC Partners. The acquisition will significantly expand Oral Care’s presence in the Netherlands and marks another step in its aspirations in becoming a leading dental care group in Northern Europe.

19 February 2025

Axcel acquires De Tandartsengroep from HC Partners through its portfolio company Oral Care to create Northern European dental group

16 December 2024

De Brauw advises underwriters on NewAmsterdam Pharma's USD 479 million public offering of shares and pre-funded warrants

De Brauw advised the underwriters on the upsized USD 479 million public offering of shares and pre-funded warrants by NASDAQ listed NewAmsterdam Pharma Company N.V.

All matters

Landscape debrauw paper blackstone duo high res 3

We cover a broad spectrum of Life Sciences work for pharmaceutical companies, biotech firms and medical supply companies.

On behalf of our strong client base in the food and drink industry (Unilever, PepsiCo, Danone, JDE and P&G to name but a few), we have a leading role in developments relating to food claims and the actions taken by the European Food Safety Authority (EFSA).

We are the patent litigation firm of choice for many multinationals wishing to coordinate their patent strategy throughout Europe. Our Patent Law practice members combine their strong foundation in patent and procedural law with their extensive knowledge of the economics of, and the mechanisms, in this sector.

Learn More about our patents practice

“A strong Dutch full service firm with the patent department also having a focus on Life Sciences... unique in combining legal and technical thinking when developing strategies and arguments. This team is unique in their extraordinary ability to learn the subject matter in a very short time, applying it in court and turn it into victory... They are a pleasure to work with both on a professional and a personal level.”